Myopia Intervention in Children and Adolescents and Establishment of a Precise Intervention Model

NCT05357326 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Myopia

Interventions

DRUG: Atropine Sulfate 0.01% Eye Drop
DEVICE: Orthokeratology
DRUG: Atropine Sulfate 0.04% Eye Drop

Sponsor

Shanghai Eye Disease Prevention and Treatment Center

Collaborators

[object Object]
[object Object]